InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the detailed record of transactions filed by Bandari Jathin, Directeur Médical. Director active across 1 company, notably Protara Therapeutics, Inc.. Aggregated, 8 filings have been published. Activity tracked since 10 January 2022. The latest transaction was disclosed on 19 January 2024 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 条申报中的 8 条
Bandari Jathin is Directeur Médical and appears in filings related to Protara Therapeutics, Inc. (XNAS) as Chief Medical Officer. He has 8 filings in total, and across the 8 sampled filings between 2022-01-12 and 2024-01-23, the most frequent transaction nature is Tax withholding, with buy and sell amounts shown as 0.